Cited by

• CRISPR-Cas Technology as a Revolutionary Genome Editing tool: Mechanisms and Biomedical Applications.

  Ebrahimi S, Khosravi MA, Raz A, Karimipoor M, Parvizi P. Ebrahimi S, et al. Iran Biomed J. 2023 Sep 1;27(5):219-46. doi: 10.61186/ibj.27.5.219. Epub 2023 Jun 18. Iran Biomed J. 2023. PMID: 37873636 Free PMC article. Review.
• A critical review on therapeutic approaches of CRISPR-Cas9 in diabetes mellitus.

  Bora J, Dey A, Lyngdoh AR, Dhasmana A, Ranjan A, Kishore S, Rustagi S, Tuli HS, Chauhan A, Rath P, Malik S. Bora J, et al. Naunyn Schmiedebergs Arch Pharmacol. 2023 Dec;396(12):3459-3481. doi: 10.1007/s00210-023-02631-1. Epub 2023 Jul 31. Naunyn Schmiedebergs Arch Pharmacol. 2023. PMID: 37522916 Review.
• Chitosan-Based Nanoparticles for Nucleic Acid Delivery: Technological Aspects, Applications, and Future Perspectives.

  Karayianni M, Sentoukas T, Skandalis A, Pippa N, Pispas S. Karayianni M, et al. Pharmaceutics. 2023 Jun 29;15(7):1849. doi: 10.3390/pharmaceutics15071849. Pharmaceutics. 2023. PMID: 37514036 Free PMC article. Review.
• Recent Advances in Genome-Editing Technology with CRISPR/Cas9 Variants and Stimuli-Responsive Targeting Approaches within Tumor Cells: A Future Perspective of Cancer Management.

  Allemailem KS, Almatroodi SA, Almatroudi A, Alrumaihi F, Al Abdulmonem W, Al-Megrin WAI, Aljamaan AN, Rahmani AH, Khan AA. Allemailem KS, et al. Int J Mol Sci. 2023 Apr 11;24(8):7052. doi: 10.3390/ijms24087052. Int J Mol Sci. 2023. PMID: 37108214 Free PMC article. Review.
• Recent advances in the delivery and applications of nonviral CRISPR/Cas9 gene editing.

  Sinclair F, Begum AA, Dai CC, Toth I, Moyle PM. Sinclair F, et al. Drug Deliv Transl Res. 2023 May;13(5):1500-1519. doi: 10.1007/s13346-023-01320-z. Epub 2023 Mar 29. Drug Deliv Transl Res. 2023. PMID: 36988873 Free PMC article. Review.